Clinical Trials Logo

Clinical Trial Summary

This feasibility study is for the purpose of determining if the G-Tech Device can differentiate between normal return of GI activity post-operatively and the myoelectric activity in patients who develop a POI.


Clinical Trial Description

While preventing the development of a POI is most important, POIs still occur; therefore, it is important to definitively diagnose a POI as early as possible during the post-operative course for treatment to prevent patient discomfort, complications, and extended hospital stay. The purpose of the G-Tech study is to determine if the G-Tech Device can detect a difference in the myoelectric signals from patients who develop a POI compared to those patients who do not develop a POI. It is anticipated that up to 20% of patients enrolled in this study and consented preoperatively, excluding screen failures, will show evidence of a post-operative ileus as detected by the G-Tech GutCheck Device and differentiate the myoelectric signals from the patients who do not develop a POI. Patients who are known to have developed a POI may also be selected for the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02673671
Study type Observational
Source G-Tech Corporation
Contact Steve Axelrod, PhD
Phone 650-269-1479
Email steve.axelrod@gtechhealth.com
Status Recruiting
Phase
Start date February 2016
Completion date December 2023

See also
  Status Clinical Trial Phase
Terminated NCT00443040 - Asimadoline for the Treatment of Post-Operative Ileus Phase 2
Terminated NCT01662115 - Nicotine Gum Recovery After Colorectal Surgery Phase 4
Completed NCT01869231 - Evaluating the Efficacy of Current Treatments for Reducing Postoperative Ileus N/A
Recruiting NCT04009954 - Post-operative Ileus and Gut Microbiota